发明名称 |
Respiratory disease treatment |
摘要 |
There is provided a pharmaceutical composition that is adapted for pulmonary administration by inhalation, which composition comprises a glitazone, such as pioglitazone or rosiglitazone, and one or more pharmaceutically acceptable carriers and/or excipients, and wherein the glitazone content of the composition consists of at least 95% by weight of the 5R enantiomer and less than 5% by weight of the 5S enantiomer. There is also provided a use and a kit. |
申请公布号 |
AU2009279077(B2) |
申请公布日期 |
2014.07.03 |
申请号 |
AU20090279077 |
申请日期 |
2009.08.05 |
申请人 |
PULMAGEN THERAPEUTICS (INFLAMMATION) LIMITED |
发明人 |
FINCH, HARRY;FOX, CRAIG;SAJAD, MOHAMMED |
分类号 |
A61K9/00;A61K31/427;A61P11/00 |
主分类号 |
A61K9/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|